Gene mutations behind serious bone marrow conditions identified
Inherited bone marrow failure syndrome, or IBMFS, describes a group of disorders in which inherited genetic abnormalities impair the bone marrow's ability to produce sufficient healthy blood cells. Patients with these disorders are also at increased risk of developing myelodysplastic syndromes—MDS—a group of blood cancers in which the bone marrow produces excess abnormal blood cells and…
Recent research at Kyoto University has identified specific gene mutations responsible for inherited bone marrow failure syndrome (IBMFS) and a predisposition to early myelodysplastic syndromes (MDS). These genetic abnormalities, located in the SLF2 and SMC5 genes, impair the bone marrow's ability to produce healthy blood cells and increase the risk of developing MDS.
The findings, published in the Leukemia journal, provide critical insights into the molecular mechanisms underlying these conditions and suggest potential new therapeutic strategies.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
